Fig. 4From: Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade GliomaCost-effectiveness plane indicating the incremental cost and incremental effectiveness estimates related to molecular testing for each probabilistic simulation assuming both A a no-radiation benefit and B a radiation benefitBack to article page